JUSTIN LAWANDALES: Open Payments
NPI 1356794044 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,234 in 52 payments from 14 companies in 2025. Trend: 2023 $544 · 2024 $1,400 · 2025 $1,234
Food & beverage: $1,234
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $416 |
| GENZYME CORPORATION | 4 | $192 |
| Lilly USA, LLC | 4 | $96 |
| VIVUS LLC | 5 | $91 |
| Aimmune Therapeutics, Inc. | 4 | $89 |
| Celltrion USA Inc. | 3 | $82 |
| Amgen Inc. | 2 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $49 |
| Mallinckrodt Hospital Products Inc. | 1 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
Products named: DUPIXENT, CREON, OMVOH, PANCREAZE, LINZESS, VEGZELMA, MAVYRET, RINVOQ.
Industry payments across FL — which companies pay providers there.
